Drugs / Catapresan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT04564430 | Mar → Dec 2021 | arthropathy, clubfoot, congenital deformities of limbs, exostosis, Dupuytren subungual +8 | Odense University Hospital | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00421863 Background | Feb 2005 → Jan 2009 | hypertensive disorder | Heart Care Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Catapresan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00421863 ↗ |
| Route | Intravenous | “single intravenous bolus of 3mcg/kg Catapresan” NCT04564430 ↗ |